Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-9B3144DF-20260531 | Data as of 2026-05-31
Executive Summary: carta eshares operates in the Healthcare industry with a market cap of $5.93B. The stock trades at 65.83x earnings and exhibits 24.9% top-line growth. Our derived fair value is $2318.4.
Rating: Overweight | Target Price: $2318.4 | Next Earnings: Jun 14
Download Full PDF Report
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $1932 would be bullish.
On-chain money flow shows 32%% increase in smart money index, reinforcing the technical setup.
EPS of $25.52 reveals improving earnings quality. DuPont analysis highlights capital efficiency as the key ROE driver.
Free cash flow conversion remains robust at 75%, supporting the 0.81% dividend and buybacks.
Options skew is toward put at the 1579.2 strike, positioning for a directional move.
Short float at 13.4% is below the sector average, reducing squeeze risk. Institutional ownership is 90%.
Beta of 1.86 suggests carta eshares is {beta_desc} volatile than the market, influencing hedging strategies.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1680 | $1596 |
| Market Cap | $5.93B | $4.74B |
| P/E Ratio | 65.83x | 56x |
| EPS (TTM) | $25.52 | $22.97 |
| Dividend Yield | 0.81% | 0.6% |
| Revenue Growth | 24.9% | 14.9% |
| Target Price | $2318.4 | - |
| Beta | 1.86 | 1.00 |